Medigene announces participation at six upcoming investor and scientific conferences

(PresseBox) (Planegg/Martinsried, ) Medigene AG (FSE: MDG1, Prime Standard, TecDAX) today announced its participation at six upcoming investor and scientific conferences:

Precision Medicine World Conference (PMWC) 2018
Date: 22 - 24 January 2018
Location: Mountain View, CA, USA
Dr. Kai Pinkernell, Chief Medical Officer of Medigene, will give a presentation during the PMWC 2018 Immunotherapy Showcase on 23 January at 2 pm on the topic "Using cutting-edge technologies to develop TCR-based immunotherapies".

ASCO-SITC Clinical Immuno-Oncology Symposium
Date: 25 - 27 January 2018
Location: San Francisco, CA, USA

BioCapital Europe
Date: 6 February 2018
Location: Amsterdam, Netherlands
Julia Hofmann, Head of Public & Investor Relations at Medigene, will hold a company presentation on 6 February at 4.40 pm.

Immuno-Oncology 360°
Date: 7 - 9 February 2018
Location: New York, USA
Dr. Thomas Taapken, CFO of Medigene, takes part in the discussion panel entitled "Raising Money in the Current Climate" on 9 February at 2 pm.

CAR-TCR Summit Europe 2018
Date: 20 - 22 February 2018
Location: London, UK
Prof. Dolores Schendel, CEO and CSO of Medigene, will hold a company presentation on 22 February.

ODDO - 11th German Conference
Date: 21 - 22 February 2018
Location: Frankfurt; Germany

This press release contains forward-looking statements representing the opinion of Medigene as of the date of this release. The actual results achieved by Medigene may differ significantly from the forward-looking statements made herein. Medigene is not bound to update any of these forward-looking statements. Medigene® is a registered trademark of Medigene AG. This trademark may be owned or licensed in select locations only.


MediGene AG
Lochhamer Str. 11
D-82152 Planegg/Martinsried
Julia Hofmann
Medigene AG
Social Media